Literature DB >> 17975662

Cardiac growth and angiogenesis coordinated by intertissue interactions.

Kenneth Walsh1, Ichiro Shiojima.   

Abstract

Cardiac hypertrophy and angiogenesis are coordinately regulated during physiological or adaptive cardiac growth, and disruption of the balanced growth and angiogenesis leads to contractile dysfunction and heart failure. Coordination of growth and angiogenesis is in part mediated by the secretion of angiogenic growth factors from myocytes in response to hypertrophic stimuli, which enables the vasculature to "catch up" to the growth of the myocardium. In this issue of the JCI, two studies provide novel insights into the regulatory mechanisms of cardiac growth and coronary angiogenesis. Heineke et al. demonstrate that GATA4 acts as a stress-responsive transcription factor in murine cardiac myocytes that induces the expression of angiogenic growth factors (see the related article beginning on page 3198). Tirziu et al. show that enhanced coronary angiogenesis per se leads to hypertrophic growth of myocytes through a nitric oxide-dependent mechanism (see the related article beginning on page 3188). These studies, together with previous reports, suggest the existence of reciprocal signals between the myocardium and the vasculature that promote the growth of each other in a paracrine fashion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975662      PMCID: PMC2045631          DOI: 10.1172/JCI34126

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy.

Authors:  D Abraham; R Hofbauer; R Schäfer; R Blumer; P Paulus; A Miksovsky; H Traxler; A Kocher; S Aharinejad
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

Review 3.  Angiogenesis in skeletal and cardiac muscle.

Authors:  O Hudlicka; M Brown; S Egginton
Journal:  Physiol Rev       Date:  1992-04       Impact factor: 37.312

4.  Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA.

Authors:  F Charron; G Tsimiklis; M Arcand; L Robitaille; Q Liang; J D Molkentin; S Meloche; M Nemer
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

5.  Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.

Authors:  Yuval Dor; Valentin Djonov; Rinat Abramovitch; Ahuva Itin; Glenn I Fishman; Peter Carmeliet; Gadi Goelman; Eli Keshet
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

6.  Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.

Authors:  C Morisco; K Seta; S E Hardt; Y Lee; S F Vatner; J Sadoshima
Journal:  J Biol Chem       Date:  2001-05-29       Impact factor: 5.157

7.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

8.  The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes.

Authors:  Q Liang; R J Wiese; O F Bueno; Y S Dai; B E Markham; J D Molkentin
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth.

Authors:  Akihiro Takahashi; Yasuko Kureishi; Jiang Yang; Zhengyu Luo; Kun Guo; Debabrata Mukhopadhyay; Yuri Ivashchenko; Didier Branellec; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice.

Authors:  Daniela Tirziu; Emmanuel Chorianopoulos; Karen L Moodie; Robert T Palac; Zhen W Zhuang; Marc Tjwa; Carmen Roncal; Ulf Eriksson; Qiangwei Fu; Arye Elfenbein; Amy E Hall; Peter Carmeliet; Lieve Moons; Michael Simons
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more
  36 in total

1.  Temporal and spatial changes in collateral formation and function during chronic myocardial ischemia.

Authors:  Michael P Robich; Robert M Osipov; Louis M Chu; Jun Feng; Thomas A Burgess; Shizu Oyamada; Richard T Clements; Roger J Laham; Frank W Sellke
Journal:  J Am Coll Surg       Date:  2010-08-21       Impact factor: 6.113

Review 2.  Cytostatic drugs, neuregulin activation of erbB receptors, and angiogenesis.

Authors:  Nadia Hedhli; Kerry Strong Russell
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

3.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kosha Ruparel; Nancy K Sweitzer; James C Fang; Wayne C Levy; Douglas B Sawyer; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

Review 4.  The Future of Cardiovascular Regenerative Medicine.

Authors:  Richard T Lee; Kenneth Walsh
Journal:  Circulation       Date:  2016-06-21       Impact factor: 29.690

5.  Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis.

Authors:  Ji Ho Suh; Li Lai; Deokhwa Nam; Jong Kim; Juyeon Jo; George E Taffet; Eunah Kim; Jason T Kaelber; Hyun-Kyoung Lee; Mark L Entman; John P Cooke; Erin L Reineke
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

Review 6.  Heart failure associated with sunitinib: lessons learned from animal models.

Authors:  Colin F Greineder; Sarah Kohnstamm; Bonnie Ky
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

7.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 8.  Placental growth factor as a protective paracrine effector in the heart.

Authors:  Federica Accornero; Jeffery D Molkentin
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

9.  The role of interleukin-6 in the formation of the coronary vasculature.

Authors:  Indroneal Banerjee; John W Fuseler; Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Microsc Microanal       Date:  2009-08-27       Impact factor: 4.127

10.  Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.

Authors:  V Montiel; E Leon Gomez; C Bouzin; H Esfahani; M Romero Perez; I Lobysheva; O Devuyst; C Dessy; J L Balligand
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.